Changes of CXCL12, CXCL14 and PDGF levels in the brain of patients with idiopathic demyelinating optic neuritis and neuromyelitis optical

被引:1
|
作者
Chen, Tingjun [1 ]
Li, Zhaohui [1 ]
Jiang, Zhaocai [1 ,4 ]
Liu, Zihao [1 ,5 ]
Xu, Quangang [3 ]
Huang, Dehui [3 ]
Lin, Qing [2 ]
Wei, Shihui [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dep Neuroophthalmol, Beijing, Peoples R China
[2] Univ Texas Arlington, Coll Sci, Dept Psychol, Arlington, TX 76019 USA
[3] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China
[4] LongFu Hosp, Dept Ophthalmol, Being, Peoples R China
[5] Dongzhimen Hosp, Dept Ophthalmol, Beijing, Peoples R China
基金
美国国家卫生研究院;
关键词
Platelet-derived growth factor; CXC-motif ligand 12; CXC-motif ligand 14; Idiopathic demyelinating optic neuritis; Neuromyelitis optica; Enzyme linked immunosorbent assay; Biomarkers; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; OLIGODENDROCYTE PROGENITORS; DIFFERENTIAL-DIAGNOSIS; SYNAPTIC PLASTICITY; TRANSVERSE MYELITIS; GROWTH-FACTORS; EXPRESSION; CELLS; PROLIFERATION;
D O I
10.1016/bjneuroim.2014.12.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The CXC chemokines (CXC-motif ligand 12 and CXC-motif ligand 14) and platelet-derived growth factor are suggested to modulate remyelination in the course of many demyelinating diseases. The present study compared the difference in the brain levels of these chemokines between patients with idiopathic demyelinating optic neuritis (IDON) and neuromyelitis optica (NMO) by measuring their concentrations in the cerebrospinal fluid using an enzyme linked immunosorbent assay. Our data indicate that the prognosis of neuritis depends on the remyelinating process that is impaired due to decreased chemokines. The much lower levels of chemokines would specifically indicate the severe neuritis, such as NMO. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [2] Expression of CXCL12 and CXCL14 during eye development in chick and mouse
    Ojeda, Ana F.
    Munjaal, Ravi P.
    Lwigale, Peter Y.
    GENE EXPRESSION PATTERNS, 2013, 13 (08) : 303 - 310
  • [3] Serum CXCL10, CXCL11, CXCL12, and CXCL14 chemokine patterns in patients with acute liver injury
    Chalin, Arnaud
    Lefevre, Benjamin
    Devisme, Christelle
    Pronier, Charlotte
    Carriere, Virginie
    Thibault, Vincent
    Amiot, Laurence
    Samson, Michel
    CYTOKINE, 2018, 111 : 500 - 504
  • [4] Serum CXCL10, CXCL11, CXCL12 and CXCL14 chemokine patterns in patients with acute liver injury
    Chalin, A.
    Lefevre, B.
    Devisme, C.
    Carriere, V.
    Amiot, L.
    Samson, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S592 - S593
  • [5] Dimeric peptides of the C-terminal region of CXCL14 function as CXCL12 inhibitors
    Tanegashima, Kosuke
    Tsuji, Kohei
    Suzuki, Kenji
    Shigenaga, Akira
    Otaka, Akira
    Hara, Takahiko
    FEBS LETTERS, 2013, 587 (23): : 3770 - 3775
  • [6] Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4
    Collins, Paul J.
    McCully, Michelle L.
    Martinez-Munoz, Laura
    Santiago, Cesar
    Wheeldon, James
    Caucheteux, Stephan
    Thelen, Sylvia
    Cecchinato, Valentina
    Laufer, Julia M.
    Purvanov, Vladimir
    Monneau, Yoan R.
    Lortat-Jacob, Hugues
    Legler, Daniel F.
    Uguccioni, Mariagrazia
    Thelen, Marcus
    Piguet, Vincent
    Mellado, Mario
    Moser, Bernhard
    FASEB JOURNAL, 2017, 31 (07): : 3084 - 3097
  • [7] The chemokines CXCL12 and CXCL14 differentially regulate connective tissue markers during limb development
    Nassari, Sonya
    Blavet, Cedrine
    Bonnin, Marie-Ange
    Stricker, Sigmar
    Duprez, Delphine
    Fournier-Thibault, Claire
    SCIENTIFIC REPORTS, 2017, 7
  • [8] The chemokines CXCL12 and CXCL14 differentially regulate connective tissue markers during limb development
    Sonya Nassari
    Cédrine Blavet
    Marie-Ange Bonnin
    Sigmar Stricker
    Delphine Duprez
    Claire Fournier-Thibault
    Scientific Reports, 7
  • [10] CXCL14, an inhibitor of CXCL12/CXCR4 signaling, is upregulated in prostate cancer bone metastasis.
    Dowell, Alexander
    Clines, Katrina
    Morrissey, Colm
    Wei, Shi
    Clines, Gregory
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S64 - S65